410 related articles for article (PubMed ID: 33143193)
1. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
[TBL] [Abstract][Full Text] [Related]
3. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
4. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
5. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
6. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
[TBL] [Abstract][Full Text] [Related]
8. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
Babenko NA
Med Sci Monit; 2005 May; 11(5):BR131-138. PubMed ID: 15874883
[TBL] [Abstract][Full Text] [Related]
9. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
[TBL] [Abstract][Full Text] [Related]
10. Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons.
Nusshold C; Uellen A; Bernhart E; Hammer A; Damm S; Wintersperger A; Reicher H; Hermetter A; Malle E; Sattler W
Biochim Biophys Acta; 2013 Dec; 1831(12):1665-78. PubMed ID: 23973266
[TBL] [Abstract][Full Text] [Related]
11. Role of Inositol Phosphosphingolipid Phospholipase C1, the Yeast Homolog of Neutral Sphingomyelinases in DNA Damage Response and Diseases.
Tripathi K
J Lipids; 2015; 2015():161392. PubMed ID: 26346287
[TBL] [Abstract][Full Text] [Related]
12. Signalling sphingomyelinases: which, where, how and why?
Levade T; Jaffrézou JP
Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
[TBL] [Abstract][Full Text] [Related]
14. Regulation of sphingomyelin metabolism.
Bienias K; Fiedorowicz A; Sadowska A; Prokopiuk S; Car H
Pharmacol Rep; 2016 Jun; 68(3):570-81. PubMed ID: 26940196
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin-degrading pathways in human cells role in cell signalling.
Levade T; Andrieu-Abadie N; Ségui B; Augé N; Chatelut M; Jaffrézou JP; Salvayre R
Chem Phys Lipids; 1999 Nov; 102(1-2):167-78. PubMed ID: 11001571
[TBL] [Abstract][Full Text] [Related]
16. Hexachlorobenzene-induced alterations on neutral and acidic sphingomyelinases and serine palmitoyltransferase activities. A time course study in two strains of rats.
Billi de Catabbi SC; Setton-Advruj CP; Sterin-Speziale N; San Martín de Viale LC; Cochón AC
Toxicology; 2000 Aug; 149(2-3):89-100. PubMed ID: 10967406
[TBL] [Abstract][Full Text] [Related]
17. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
19. Temporal expression profiles of ceramide and ceramide-related genes in wild-type and mPer1/mPer2 double knockout mice.
Jang YS; Kang YJ; Kim TJ; Bae K
Mol Biol Rep; 2012 Apr; 39(4):4215-21. PubMed ID: 21773940
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
